Concepedia
Statistics
Publications
7
Citations
244
H-Index
Active since
2019
Affiliations
Oregon Health & Science University(Current)
City Of Hope National Medical Center
Millennium Engineering and Integration (United States)
Takeda (United States)
Nur Bruss is an author at Oregon Health & Science University specializing in oncology, medicine, and molecular oncology.
Publications per year
2019–2023
Cyclin-Dependent Kinase-9 Is a Therapeutic Target in MYC-Expressing Diffuse Large B-Cell Lymphoma
Taylor Hashiguchi, Nur Bruss, Scott Best et al. · Molecular Cancer Therapeutics · 2019 · 58 citations
Medicine, Cancer Biology, Oncology +15
Targeting ubiquitin-activating enzyme induces ER stress–mediated apoptosis in B-cell lymphoma cells
Scott Best, Taylor Hashiguchi, Adam S. Kittai et al. · Blood Advances · 2019 · 55 citations · Full text
Life Sciences, Cell Biology, Oncology +17
Immunomodulatory effects of pevonedistat, a NEDD8-activating enzyme inhibitor, in chronic lymphocytic leukemia-derived T cells
Scott Best, Vi Lam, Tingting Liu et al. · Leukemia · 2020 · 38 citations · Full text
Life Sciences, Immunology, Oncology +16
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma
Elana Thieme, Nur Bruss, Duanchen Sun et al. · Molecular Cancer · 2023 · 35 citations · Full text
Medicine, Cancer Biology, Oncology +17
Dual BTK/SYK inhibition with CG-806 (luxeptinib) disrupts B-cell receptor and Bcl-2 signaling networks in mantle cell lymphoma
Elana Thieme, Tingting Liu, Nur Bruss et al. · Cell Death and Disease · 2022 · 25 citations · Full text
Medicine, Hematology, Pharmacology +17
1–5 of 7